Search results
NEW DATA PRESENTED AT ATS 2024 SHOW THE POTENTIAL OF TEZSPIRE® TO HELP PATIENTS LIVING WITH COPD
WJTV Jackson· 5 days agoAmgen (NASDAQ:AMGN) and AstraZeneca today announced the results of the Phase 2a COURSE trial evaluating Tezspire® (tezepelumab-ekko) in people with moderate to very severe ...
GSK Sees Positive Results for Severe Asthma Treatment Depemokimab
Market Watch· 3 days agoBy Najat Kantouar GSK said that it had positive results from phase III trials of depemokimab, aimed at assessing the drug's efficacy and safety in adults and...
GSK Potential Blockbuster Asthma Drug Shows Promise in Latest Trial — Update
Morningstar· 3 days agoBy Najat Kantouar and Helena Smolak GSK's experimental drug for asthma met its goals in the latest trial, moving a treatment with potential blockbuster sales of 3 billion ...
Mask restrictions prompt concern, fear from disabled North Carolina residents
ABC News· 18 hours agoDisabled North Carolina residents say a mask restriction that is under consideration in the state...
Signs and Symptoms of Esophagitis
Health via Yahoo News· 5 days agoSeek immediate medical attention if you experience any of the following: Severe chest pain that lasts more than a few minutes Inability to swallow or...
Tezepelumab Shows Potential for COPD, Negative Trial Notwithstanding
MedPage Today· 2 days agoAsthma drug may benefit patients with blood eosinophil counts indicative of type 2 inflammation
J&J (JNJ) to Boost Dermatology Portfolio With New Acquisition
Zacks via Yahoo Finance· 7 days agoThe company’s pipeline includes a phase I ready candidate, PX128, a bispecific antibody targeting...
Extreme heat associated with children's asthma hospital visits
Medical Xpress· 5 days agoFor children seeking care at a California urban pediatric health center, extreme heat events were...
Biotech Stock Roundup: BIIB's Acquisition, PTCT, LRMR Gain on Updates & More News
Zacks· 1 day agoUpdates From Biogen: Biogen (BIIB Quick QuoteBIIB - Free Report) entered into an agreement to acquire privately-held clinical-stage biotechnology company Human Immunology Biosciences for an ...
AstraZeneca’s fasenra asthma drug shows promise for COPD treatment
BioPharma-Reporter· 3 days agoThis approval extends Fasenra's availability to over 80 countries, including the US, EU, and Japan....
